NCT05035407 2025-12-02T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial CancersNational Institutes of Health Clinical Center (CC)Phase 1 Terminated36 enrolled 7 charts